4
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Specificities of Monoclonal Antibodies to Domain I of α-Gliadins

, , , &
Pages 212-216 | Received 23 Jul 1992, Accepted 22 Sep 1992, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

R. G. Shidrawi, P. Day, R. Przemioslo, H. J. Ellis, J. M. Nelufer & P. J. Ciclitira. (1995) In Vitro Toxicity of Gluten Peptides in Coeliac Disease Assessed by Organ Culture. Scandinavian Journal of Gastroenterology 30:8, pages 758-763.
Read now

Articles from other publishers (8)

Cui-Ping Ren, Quan Liu, Feng-Chun Liu, Feng-Yu Zhu, Shi-Xiang Cui, Zhen Liu, Wen-Da Gao, Miao Liu, Yong-Sheng Ji & Ji-Jia Shen. (2017) Development of monoclonal antibodies against Sj29 and its possible application for schistosomiasis diagnosis. International Journal of Infectious Diseases 61, pages 74-78.
Crossref
Klaus‐Peter Zimmer, Hassan Naim, Peter Weber, H. Julia Ellis & Paul J. Ciclitira. (1998) Targeting of gliadin peptides, CD8, α/β‐TCR, and γ/δ‐TCR to Golgi complexes and vacuoles within celiac disease enterocytes. The FASEB Journal 12:13, pages 1349-1357.
Crossref
Carlo Catassi. 1996. Autoantibodies. Autoantibodies 285 290 .
K. P. Zimmer, P. Ciclitira & P. Weber. 1996. Ökosystem Darm VII. Ökosystem Darm VII 227 242 .
R Tighe & P J Ciclitira. (1995) Molecular biology of coeliac disease.. Archives of Disease in Childhood 73:3, pages 189-191.
Crossref
M.Richard Tighe, Paul J. Ciclitira & P.D. Howdle. (1995) 2 The gluten-host interaction. Baillière's Clinical Gastroenterology 9:2, pages 211-230.
Crossref
R Sturgess, P Day, H.J Ellis, M Kontakou, P.J Ciclitira, K.E.A Lundin & H.A Gjertsen. (1994) Wheat peptide challenge in coeliac disease. The Lancet 343:8900, pages 758-761.
Crossref
H.J. Ellis, A.P. Doyle, H. Wieser, R.P. Sturgess, P. Day & P.J. Ciclitira. (1994) Measurement of gluten using a monoclonal antibody to a sequenced peptide of α-gliadin from the coeliac-activating domain I. Journal of Biochemical and Biophysical Methods 28:1, pages 77-82.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.